Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Related Citations for PubMed (Select 20201988)

1.

Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody.

Ponte JF, Ponath P, Gulati R, Slavonic M, Paglia M, O'Shea A, Tone M, Waldmann H, Vaickus L, Rosenzweig M.

Immunology. 2010 Jun;130(2):231-42. doi: 10.1111/j.1365-2567.2009.03228.x. Epub 2010 Feb 26.

2.

Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells.

Lee SK, Choi BK, Kim YH, Kang WJ, Kim KH, Sakaguchi S, Suh JH, Kim TY, Kwon BS.

Immunology. 2006 Dec;119(4):479-87.

3.

Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis.

Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, Thomson NC, Liew FY.

Eur J Immunol. 2005 Dec;35(12):3581-90.

PMID:
16285015
4.

Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody.

Zhou P, Qiu J, L'Italien L, Gu D, Hodges D, Chao CC, Schebye XM.

J Immunother. 2010 Oct;33(8):789-97. doi: 10.1097/CJI.0b013e3181ee6ba9.

PMID:
20842058
5.
6.

Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.

Cohen AD, Schaer DA, Liu C, Li Y, Hirschhorn-Cymmerman D, Kim SC, Diab A, Rizzuto G, Duan F, Perales MA, Merghoub T, Houghton AN, Wolchok JD.

PLoS One. 2010 May 3;5(5):e10436. doi: 10.1371/journal.pone.0010436.

7.

Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy.

Boczkowski D, Lee J, Pruitt S, Nair S.

Cancer Gene Ther. 2009 Dec;16(12):900-11. doi: 10.1038/cgt.2009.39. Epub 2009 Jun 5.

PMID:
19498460
8.

Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.

Cohen AD, Diab A, Perales MA, Wolchok JD, Rizzuto G, Merghoub T, Huggins D, Liu C, Turk MJ, Restifo NP, Sakaguchi S, Houghton AN.

Cancer Res. 2006 May 1;66(9):4904-12.

9.

Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis.

Bae E, Kim WJ, Kang YM, Suk K, Koh EM, Cha HS, Ahn KS, Huh TL, Lee WH.

Clin Exp Immunol. 2007 Jun;148(3):410-8. Epub 2007 Mar 15.

11.
12.

Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy.

Mittler RS, Bailey TS, Klussman K, Trailsmith MD, Hoffmann MK.

J Exp Med. 1999 Nov 15;190(10):1535-40.

13.

Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.

Mitsui J, Nishikawa H, Muraoka D, Wang L, Noguchi T, Sato E, Kondo S, Allison JP, Sakaguchi S, Old LJ, Kato T, Shiku H.

Clin Cancer Res. 2010 May 15;16(10):2781-91. doi: 10.1158/1078-0432.CCR-09-3243. Epub 2010 May 11.

14.

4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.

Munks MW, Mourich DV, Mittler RS, Weinberg AD, Hill AB.

Immunology. 2004 Aug;112(4):559-66.

15.

A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.

Jazani NH, Sohrabpour M, Mazloomi E, Shahabi S.

FEMS Immunol Med Microbiol. 2011 Feb;61(1):54-62. doi: 10.1111/j.1574-695X.2010.00747.x. Epub 2010 Nov 5.

16.

Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.

Haque A, Stanley AC, Amante FH, Rivera Fde L, Zhou Y, Kuns RD, Yardley V, Sakaguchi S, Hill GR, Engwerda CR.

J Immunol. 2010 Mar 1;184(5):2583-92. doi: 10.4049/jimmunol.0903080. Epub 2010 Feb 5.

17.

Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.

Ramirez-Montagut T, Chow A, Hirschhorn-Cymerman D, Terwey TH, Kochman AA, Lu S, Miles RC, Sakaguchi S, Houghton AN, van den Brink MR.

J Immunol. 2006 Jun 1;176(11):6434-42.

18.

Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma.

Heier I, Hofgaard PO, Brandtzaeg P, Jahnsen FL, Karlsson M.

Clin Exp Immunol. 2008 May;152(2):381-7. doi: 10.1111/j.1365-2249.2008.03642.x. Epub 2008 Mar 12.

20.

Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.

Cho JS, Hsu JV, Morrison SL.

Cancer Immunol Immunother. 2009 Jul;58(7):1057-69. doi: 10.1007/s00262-008-0622-2. Epub 2008 Nov 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk